Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.23% | 8.36% | 6.10% | 5.08% | 6.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.23% | 8.36% | 6.10% | 5.08% | 6.54% |
| Cost of Revenue | 9.23% | 8.52% | 4.74% | 3.83% | 6.48% |
| Gross Profit | 7.75% | 8.29% | 6.76% | 5.68% | 6.56% |
| SG&A Expenses | 8.64% | 8.80% | 6.90% | 5.76% | 8.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -240.20% | -442.88% | -1,297.92% | -579.55% | -5.73% |
| Total Operating Expenses | 8.91% | 8.42% | 5.54% | 4.27% | 6.98% |
| Operating Income | 6.41% | 8.22% | 7.63% | 7.26% | 5.34% |
| Income Before Tax | -31.60% | -42.67% | -2.21% | -2.05% | -1.44% |
| Income Tax Expenses | -38.96% | -25.66% | 32.83% | 91.38% | 57.86% |
| Earnings from Continuing Operations | -27.76% | -49.92% | -14.53% | -26.86% | -17.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.76% | -49.92% | -14.53% | -26.86% | -17.58% |
| EBIT | 6.41% | 8.22% | 7.63% | 7.26% | 5.34% |
| EBITDA | 42.72% | 8.66% | 7.93% | 7.27% | 5.91% |
| EPS Basic | -27.77% | -49.97% | -14.68% | -27.03% | -18.34% |
| Normalized Basic EPS | 22.26% | 11.49% | 4.39% | 6.19% | -1.98% |
| EPS Diluted | -27.78% | -49.98% | -14.65% | -27.02% | -17.78% |
| Normalized Diluted EPS | 22.26% | 11.53% | 4.43% | 6.28% | -1.20% |
| Average Basic Shares Outstanding | 0.00% | 0.09% | 0.19% | 0.24% | 0.94% |
| Average Diluted Shares Outstanding | 0.00% | 0.06% | 0.15% | 0.16% | 0.16% |
| Dividend Per Share | 11.74% | 11.74% | 9.03% | 9.03% | 4.76% |
| Payout Ratio | 0.55% | 1.26% | 0.32% | 0.44% | 0.28% |